Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inner Mongolia Changsheng Pharmaceutical manufactures commercial-scale active pharmaceutical ingredients (APIs) including multiple penicillin and cephalosporin antibiotics, amoxicillin, and ampicillin, which are certified in several global markets (FDA, EU CEP), but the company faced EMA export restrictions in 2018 for GMP deficiencies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inner Mongolia Changsheng Pharmaceutical.